An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Since the NHS Jewish BRCA Testing Programme began in January 2023, around 11,000 saliva tests have been processed, with 235 people (2.1%) testing positive for a BRCA gene mutation, according to new ...
SEATTLE — The BRCA gene is commonly recognized for its link to breast and ovarian cancer risk among women. Mutations in BRCA1 and BRCA2 have been associated with increased risk for the cancers, but ...
Over 20% of high-grade serous ovarian cancer patients have BRCA mutations, and up to 50% exhibit HRD, impacting DNA repair pathways. Global guidelines recommend BRCA and HRD testing, but many eligible ...
Only 23.3% of ovarian cancer patients receive BRCA testing, leading to higher treatment costs and advanced therapy lines. Non-White and low-income patients face increased financial toxicity, ...
Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 ...
Timely next-generation sequencing testing in patients with metastatic prostate cancer: A comparative analysis between Medicare Advantage and traditional Medicare. This is an ASCO Meeting Abstract from ...
Strangely, I felt calm and prepared. I knew catching it early was key, and I knew about the range of treatment options ...
Gila Pfeffer is a humor writer who splits her time between NYC and London. The following is an adapted excerpt from her memoir, "Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences." ...
From left: Dr Allan Njau, Consultant Anatomic and Molecular Pathologist, Dr Affrin Shaffi, and Dr Njoki Njiraini during the AstraZeneca BRCA testing launch in Nairobi, November 28, 2025. [Ryan Kerubo, ...
Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results